MDM2 promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects

References

• TorreLABrayFSiegelRLFerlayJLortet-TieulentJJemalAGlobal cancer statistics, 2012CA Cancer J Clin20156528710825651787
   PubMed Web of Science ®Google Scholar
• PharoahPDDunningAMPonderBAEastonDFAssociation studies for finding cancer-susceptibility genetic variantsNat Rev Cancer200441185086015516958
   PubMed Web of Science ®Google Scholar
• XuCZhuJFuWMDM4 rs4245739 A > C polymorphism correlates with reduced overall cancer risk in a meta-analysis of 69477 subjectsOncotarget2016744717187172627687591
   PubMedGoogle Scholar
• LevineAJp53, the cellular gatekeeper for growth and divisionCell19978833233319039259
   PubMed Web of Science ®Google Scholar
• LevineAJFinlayCAHindsPWP53 is a tumor suppressor geneCell2004116suppl 2S67S7015055586
   PubMedGoogle Scholar
• MichaelDOrenMThe p53 and Mdm2 families in cancerCurr Opin Genet Dev2002121535911790555
   PubMed Web of Science ®Google Scholar
• BarakYGottliebEJuvengershonTOrenMRegulation of mdm2 expression by p53: alternative promoters produce transcripts with non-identical translation potentialGenes Dev1994815173917497958853
   PubMed Web of Science ®Google Scholar
• ZaubermanAFlusbergDHauptYBarakYOrenMA functional p53-responsive intronic promoter is contained within the human mdm2 geneNucleic Acids Res1995231425847651818
   PubMed Web of Science ®Google Scholar
• BondGLHuWBondEEA single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humansCell2004119559160215550242
   PubMed Web of Science ®Google Scholar
• LalondeMEOuimetMLariviereMKritikouEASinnettDIdentification of functional DNA variants in the constitutive promoter region of MDM2Hum Genomics2012611523244604
   PubMedGoogle Scholar
• JinMJZhangSSZhangYJPolymorphisms in P53 pathway genes and colorectal cancer riskChin J Dig20082810703705
   Google Scholar
• DongDGaoXZhuZYuQBianSGaoYA 40-bp insertion/deletion polymorphism in the constitutive promoter of MDM2 confers risk for hepatocellular carcinoma in a Chinese populationGene20124971667022285926
   PubMedGoogle Scholar
• SalimiSHajizadehAKhodamianMPejmanAFazeliKYaghmaeiMAge-dependent association of MDM2 promoter polymorphisms and uterine leiomyoma in South-East Iran: a preliminary reportJ Obstet Gynaecol Res201541572973425511444
   PubMedGoogle Scholar
• CaoYYZhangXFGuoWWangRGeHZhangJHAssociation of the MDM2 polymorphisms with susceptibility of esophageal squamous cell carcinoma and that of gastric cardiac adenocarcinomaTumor2007278628632
   Google Scholar
• ZhangLZhuZWuHWangKAssociation between SNP309 and del1518 polymorphism in MDM2 homologue and esophageal squamous cell carcinoma risk in Chinese population of shandong provinceAnn Clin Lab Sci201545443343726275695
   PubMed Web of Science ®Google Scholar
• HeJShiTYZhuMLWangMYLiQXWeiQYAssociations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysisInt J Cancer201313381765177523400628
   PubMed Web of Science ®Google Scholar
• HeJXiBRuiterRAssociation of LEP G2548A and LEPR Q223R polymorphisms with cancer susceptibility: evidence from a meta-analysisPLoS One2013810e7513524146750
   PubMed Web of Science ®Google Scholar
• HeJWangFZhuJHChenWCuiZJiaWHNo association between MTR rs1805087 A > G polymorphism and non-Hodgkin lymphoma susceptibility: evidence from 11 486 subjectsLeuk Lymphoma201556376376724956146
   PubMed Web of Science ®Google Scholar
• HeJLiaoXYZhuJHAssociation of MTHFR C677T and A1298C polymorphisms with non-Hodgkin lymphoma susceptibility: evidence from a meta-analysisSci Rep20144615925146845
   PubMed Web of Science ®Google Scholar
• WangDJLiYZhouRMAssociation of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancerTumor2009194892897
   Google Scholar
• SunPZhangZWanJZhaoNJinXXiaZAssociation of genetic polymorphisms in GADD45A, MDM2, and p14 ARF with the risk of chronic benzene poisoning in a Chinese occupational populationToxicol Appl Pharmacol20092401667219596022
   PubMedGoogle Scholar
• YuHLiHZhangJLiuGInfluence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysisOnco Targets Ther201696211622427785069
   PubMed Web of Science ®Google Scholar
• GansmoLBBjornslettMHalleMKMDM2 promoter polymorphism del1518 (rs3730485) and its impact on endometrial and ovarian cancer riskBMC Cancer20171719728158999
   PubMedGoogle Scholar
• GansmoLBVattenLRomundstadPAssociations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostateOncotarget2016719286372864627081698
   PubMedGoogle Scholar
• MaJZhangJNingTChenZXuCAssociation of genetic polymorphisms in MDM2, PTEN and P53 with risk of esophageal squamous cell carcinomaJ Hum Genet201257426126422336889
   PubMed Web of Science ®Google Scholar
• MaHHuZZhaiXPolymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese populationCancer Lett2006240226126716288830
   PubMedGoogle Scholar
• KangSWangDJLiWSAssociation of p73 and MDM2 polymorphisms with the risk of epithelial ovarian cancer in Chinese womenInt J Gynecol Cancer200919457257719509552
   PubMedGoogle Scholar
• HuZMaHLuDGenetic variants in the MDM2 promoter and lung cancer risk in a Chinese populationInt J Cancer200611851275127816152608
   PubMed Web of Science ®Google Scholar
• VousdenKHPrivesCBlinded by the light: the growing complexity of p53Cell2009137341319410540
   PubMed Web of Science ®Google Scholar
• AshcroftMVousdenKHRegulation of p53 stabilityOncogene199918537637764310618703
   PubMed Web of Science ®Google Scholar
• MidgleyCALaneDPp53 protein stability in tumour cells is not determined by mutation but is dependent on MDM2 bindingOncogene1997151011799294611
   PubMedGoogle Scholar
• LainSLaneDImproving cancer therapy by non-genotoxic activation of p53Eur J Cancer20033981053106012736103
   PubMed Web of Science ®Google Scholar
• LukashchukNVousdenKHUbiquitination and degradation of mutant p53Mol Cell Biol200727238284829517908790
   PubMed Web of Science ®Google Scholar
• NagSQinJSrivenugopalKSWangMZhangRThe MDM2-p53 pathway revisitedJ Biomed Res201327425427123885265
   PubMedGoogle Scholar
• JinSLevineAJThe p53 functional circuitJ Cell Sci2001114pt 234139414011739646
   PubMed Web of Science ®Google Scholar
• EngleLJSimpsonCLLandersJEUsing high-throughput SNP technologies to study cancerOncogene200625111594160116550159
   PubMedGoogle Scholar
• WangHGWuQYZhouHThe MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysisAsian Pac J Cancer Prev201415135277528125040988
   PubMedGoogle Scholar
• ZhangYYangDZhuJHChenMBShenWXHeJThe association between NQO1 Pro187Ser polymorphism and urinary system cancer susceptibility: a meta-analysis of 22 studiesCancer Invest2015332394025608636
   PubMed Web of Science ®Google Scholar
• ZhangTXieSZhuJHLiQWHeJZengAPAssociation of IL10 -819C>T and -592C>A polymorphisms with non-Hodgkin lymphoma susceptibility: evidence from published studiesJ Cancer20156870971626185532
   PubMedGoogle Scholar